BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 11, Issue 12
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (7102)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.
Item 
Count 
PDF620
HTML5905
Figures (1-1)293
Tables (1-3)284
 Sum=7102
Mar 28, 2005 (publication date) through Mar 29, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Völzke H, Robinson DM, Kleine V, Deutscher R, Hoffmann W, Lüdemann J, Schminke U, Kessler C, John U. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 2005; 11(12): 1848-1853 [PMID: 15793879 DOI: 10.3748/wjg.v11.i12.1848]
URL: https://www.wjgnet.com/1007-9327/full/v11/i12/1848.htm
Number Citing Articles
1
Vijay Laxmi Misra, Mouen Khashab, Naga Chalasani. Nonalcoholic fatty liver disease and cardiovascular risk. Current Gastroenterology Reports 2009; 11(1): 50 doi: 10.1007/s11894-009-0008-4
2
Mohammad Dehghani Firouzabadi, Amirhossein Poopak, Ali Sheikhy, Fatemeh Dehghani Firouzabadi, Fatemeh Moosaie, Soghra Rabizadeh, Sara Momtazmanesh, Manouchehr Nakhjavani, Alireza Esteghamati, Basilio Pintaudi. Nonalcoholic Fatty Liver Disease as a Potential Risk Factor for Cardiovascular Disease in Patients with Type 2 Diabetes: A Prospective Cohort Study. International Journal of Endocrinology 2024; 2024(1) doi: 10.1155/2024/5328965
3
Yasar Colak, Ebubekir Senates, Oguzhan Ozturk, Hamdi Levent Doganay, Ender Coskunpinar, Yasemin Musteri Oltulu, Ayse Eren, Onder Sahin, Seyma Ozkanli, Feruze Yilmaz Enc, Celal Ulasoglu, Ilyas Tuncer. Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders 2012; 10(2): 103 doi: 10.1089/met.2011.0111
4
Mireille A. Edens, Peter M.A. van Ooijen, Wendy J. Post, Mark J.F. Haagmans, Wisnumurti Kristanto, Paul E. Sijens, Erik J. van der Jagt, Ronald P. Stolk. Ultrasonography to Quantify Hepatic Fat Content: Validation by 1H Magnetic Resonance Spectroscopy. Obesity 2009; 17(12): 2239 doi: 10.1038/oby.2009.154
5
Giovanni Targher. Associations Between Liver Histology and Early Carotid Atherosclerosis in Subjects With Nonalcoholic Fatty Liver Disease *. Hepatology 2005; 42(4): 974 doi: 10.1002/hep.20894
6
Charalambos Vlachopoulos, Emanuel Manesis, Katerina Baou, George Papatheodoridis, John Koskinas, Dina Tiniakos, Konstantinos Aznaouridis, Athanasios Archimandritis, Christodoulos Stefanadis. Increased Arterial Stiffness and Impaired Endothelial Function in Nonalcoholic Fatty Liver Disease: A Pilot Study. American Journal of Hypertension 2010; 23(11): 1183 doi: 10.1038/ajh.2010.144
7
Till Ittermann, Robin Haring, Henri Wallaschofski, Sebastian E. Baumeister, Matthias Nauck, Marcus Dörr, Markus M. Lerch, Henriette E. Meyer zu Schwabedissen, Dieter Rosskopf, Henry Völzke. Inverse Association Between Serum Free Thyroxine Levels and Hepatic Steatosis: Results from the Study of Health in Pomerania. Thyroid 2012; 22(6): 568 doi: 10.1089/thy.2011.0279
8
Robert J. Wong, Fasiha Kanwal, Zobair M. Younossi, Aijaz Ahmed. Hepatitis C Virus Infection and Coronary Artery Disease Risk: A Systematic Review of the Literature. Digestive Diseases and Sciences 2014; 59(7): 1586 doi: 10.1007/s10620-014-3222-3
9
Ajay Duseja, Shivaram P. Singh, Vivek A. Saraswat, Subrat K. Acharya, Yogesh K. Chawla, Subhankar Chowdhury, Radha K. Dhiman, Rohinivilasam V. Jayakumar, Kaushal Madan, Sri P. Misra, Hrudananda Mishra, Sunil K. Modi, Arumugam Muruganathan, Banshi Saboo, Rakesh Sahay, Rajesh Upadhyay. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome—Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. Journal of Clinical and Experimental Hepatology 2015; 5(1): 51 doi: 10.1016/j.jceh.2015.02.006
10
Angel Brea Hernando, José Puzo Foncillas. Enfermedad del hígado graso no alcohólico y riesgo cardiovascular. Clínica e Investigación en Arteriosclerosis 2010; 22(6): 259 doi: 10.1016/j.arteri.2010.10.004
11
Brittany Law, Vennece Fowlkes, Jack G. Goldsmith, Wayne Carver, Edie C. Goldsmith. Diabetes-Induced Alterations in the Extracellular Matrix and Their Impact on Myocardial Function. Microscopy and Microanalysis 2012; 18(1): 22 doi: 10.1017/S1431927611012256
12
Lisa B. VanWagner, Mary E. Rinella. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2016; 15(2): 75 doi: 10.1007/s11901-016-0295-9
13
Paul E. Sijens. Parametric exploration of the liver by magnetic resonance methods. European Radiology 2009; 19(11): 2594 doi: 10.1007/s00330-009-1470-y
14
L. Fedchuk, F. Nascimbeni, R. Pais, F. Charlotte, C. Housset, V. Ratziu. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2014; 40(10): 1209 doi: 10.1111/apt.12963
15
Shivakumar Chitturi, Geoffrey C Farrell. Clues from the carotids: An appraisal of cardiovascular disease risk in non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2009; 24(8): 1315 doi: 10.1111/j.1440-1746.2009.05977.x
16
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botet. Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento ( I ). Enfermedad del hígado graso no alcohólico y su asociación con la enfermedad cardiovascular. Clínica e Investigación en Arteriosclerosis 2017; 29(3): 141 doi: 10.1016/j.arteri.2016.06.003
17
Mònica Tous, Natàlia Ferré, Anna Rull, Judit Marsillach, Blai Coll, Carlos Alonso-Villaverde, Jordi Camps, Jorge Joven. Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochemical and Biophysical Research Communications 2006; 340(4): 1078 doi: 10.1016/j.bbrc.2005.12.109
18
J. Christopher States, Sanjay Srivastava, Yu Chen, Aaron Barchowsky. Arsenic and Cardiovascular Disease. Toxicological Sciences 2009; 107(2): 312 doi: 10.1093/toxsci/kfn236
19
C. Weikert, S. Weikert, M. B. Schulze, T. Pischon, A. Fritsche, M. M. Bergmann, S. N. Willich, H. Boeing. Presence of Gallstones or Kidney Stones and Risk of Type 2 Diabetes. American Journal of Epidemiology 2010; 171(4): 447 doi: 10.1093/aje/kwp411
20
Sonja Wengert, Suemeyra Oeztuerk, Mark Martin Haenle, Wolfgang Koenig, Armin Imhof, Bernhard Otto Boehm, Manfred Wilhelm, Ren Mao, Richard Andrew Mason, Wolfgang Kratzer, _ _. Association of proinsulin and hepatic steatosis in a random, population-based sample. European Journal of Endocrinology 2013; 168(2): 195 doi: 10.1530/EJE-12-0605
21
Quentin M. Anstee, Giovanni Targher, Christopher P. Day. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nature Reviews Gastroenterology & Hepatology 2013; 10(6): 330 doi: 10.1038/nrgastro.2013.41
22
Onpan Cheung, Arun J Sanyal. Recent advances in nonalcoholic fatty liver disease. Current Opinion in Gastroenterology 2009; 25(3): 230 doi: 10.1097/MOG.0b013e3283294a18
23
Su-Yeon Choi, Donghee Kim, Jin Hwa Kang, Min Jung Park, Young Sun Kim, Seon Hee Lim, Chung Hyeon Kim, Hyo-Suk Lee. Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease; Relation of non-alcoholic fatty liver disease to carotid atherosclerosis. The Korean Journal of Hepatology 2008; 14(1): 77 doi: 10.3350/kjhep.2008.14.1.77
24
Kyung-Soo Kim, Hyun-Ju Oh, Dae-Jung Kim, Soo-Kyung Kim, Seok Won Park, Yong-Wook Cho, Kap-Bum Huh. The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels. Endocrine Journal 2013; 60(12): 1295 doi: 10.1507/endocrj.EJ13-0269
25
Mikko Kankaanpää, Hanna-Riikka Lehto, Jussi P. Pärkkä, Markku Komu, Antti Viljanen, Ele Ferrannini, Juhani Knuuti, Pirjo Nuutila, Riitta Parkkola, Patricia Iozzo. Myocardial Triglyceride Content and Epicardial Fat Mass in Human Obesity: Relationship to Left Ventricular Function and Serum Free Fatty Acid Levels. The Journal of Clinical Endocrinology & Metabolism 2006; 91(11): 4689 doi: 10.1210/jc.2006-0584
26
Giovanni Targher. Non-alcoholic Fatty Liver Disease and Cardiovascular Disease Risk. Current Cardiovascular Risk Reports 2010; 4(1): 32 doi: 10.1007/s12170-009-0070-3
27
Lucia Pacifico, Vito Cantisani, Paolo Ricci, John F Osborn, Elisa Schiavo, Caterina Anania, Eva Ferrara, Giuliano Dvisic, Claudio Chiesa. Nonalcoholic Fatty Liver Disease and Carotid Atherosclerosis in Children. Pediatric Research 2008; 63(4): 423 doi: 10.1203/PDR.0b013e318165b8e7
28
Stefano Ballestri, Alessandro Mantovani, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo. Extra-Hepatic Manifestations and Complications of Nonalcoholic Fatty Liver Disease. Future Medicinal Chemistry 2019; 11(16): 2171 doi: 10.4155/fmc-2019-0003
29
Raluca Pais, Philippe Giral, Jean-François Khan, David Rosenbaum, Chantal Housset, Thierry Poynard, Vlad Ratziu. Fatty liver is an independent predictor of early carotid atherosclerosis. Journal of Hepatology 2016; 65(1): 95 doi: 10.1016/j.jhep.2016.02.023
30
Akiomi Yoshihisa, Yasuchika Takeishi. The Liver in Systemic Diseases. 2016; : 179 doi: 10.1007/978-4-431-55790-6_9
31
Veerle Bieghs, Patrick C.N. Rensen, Marten H. Hofker, Ronit Shiri-Sverdlov. NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages. Atherosclerosis 2012; 220(2): 287 doi: 10.1016/j.atherosclerosis.2011.08.041
32
Silvia Fargion, Marianna Porzio, Anna Ludovica Fracanzani. Nonalcoholic fatty liver disease and vascular disease: State-of-the-art. World Journal of Gastroenterology 2014; 20(37): 13306-13324 doi: 10.3748/wjg.v20.i37.13306
33
Arun J. Sanyal, Colin Banas, Carol Sargeant, Velimir A. Luketic, Richard K. Sterling, Richard T. Stravitz, Mitchell L. Shiffman, Douglas Heuman, Adrian Coterrell, Robert A. Fisher, Melissa J. Contos, Alan S. Mills. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C†. Hepatology 2006; 43(4): 682 doi: 10.1002/hep.21103
34
Katharina Lau, Roberto Lorbeer, Robin Haring, Carsten O Schmidt, Henri Wallaschofski, Matthias Nauck, Ulrich John, Sebastian E Baumeister, Henry Völzke. The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study. Journal of Hypertension 2010; 28(9): 1829 doi: 10.1097/HJH.0b013e32833c211b
35
Fatemeh Ali Yari, Parisa Shabani, Sara Karami, Negar Sarmadi, Hossein Poustchi, Ahmad Reza Bandegi. Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease. BMC Endocrine Disorders 2021; 21(1) doi: 10.1186/s12902-021-00820-8
36
Andrea Sonaglioni, Federica Cerini, Gian Luigi Nicolosi, Michele Lombardo, Maria Grazia Rumi, Mauro Viganò. Left ventricular strain predicts subclinical atherosclerosis in nonadvanced nonalcoholic fatty liver disease patients. European Journal of Gastroenterology & Hepatology 2022; 34(6): 707 doi: 10.1097/MEG.0000000000002375
37
A. Federico, M. Trappoliere, C. Loguercio. Treatment of patients with non-alcoholic fatty liver disease: Current views and perspectives. Digestive and Liver Disease 2006; 38(11): 789 doi: 10.1016/j.dld.2006.04.009
38
Olufunto O. Badmus, Terry D. Hinds, David E. Stec. Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease. Current Hypertension Reports 2023; 25(8): 151 doi: 10.1007/s11906-023-01242-8
39
Paul E. Sijens. eMagRes. 2015; : 497 doi: 10.1002/9780470034590.emrstm1470
40
Amalia Gastaldelli, Michaela Kozakova, Kurt Hφjlund, Allan Flyvbjerg, Angela Favuzzi, Asimina Mitrakou, Beverley Balkau. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population #. Hepatology 2009; 49(5): 1537 doi: 10.1002/hep.22845
41
Giovanni Targher, Guido Arcaro. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007; 191(2): 235 doi: 10.1016/j.atherosclerosis.2006.08.021
42
Jianglin Fan, Yajie Chen, Haizhao Yan, Baoning Liu, Yanli Wang, Jifeng Zhang, Y. Chen, Enqi Liu, Jingyan Liang. Genomic and Transcriptomic Analysis of Hypercholesterolemic Rabbits: Progress and Perspectives. International Journal of Molecular Sciences 2018; 19(11): 3512 doi: 10.3390/ijms19113512
43
Hyuktae Kwon. Letter: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38). Journal of Obesity & Metabolic Syndrome 2020; 29(1): 76 doi: 10.7570/jomes19068
44
Kajetan Kiełbowski, Justyna Żychowska, Estera Bakinowska, Andrzej Pawlik. Non-Coding RNA Involved in the Pathogenesis of Atherosclerosis—A Narrative Review. Diagnostics 2024; 14(17): 1981 doi: 10.3390/diagnostics14171981
45
Giovanni Targher, Christopher P. Day, Enzo Bonora. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease. New England Journal of Medicine 2010; 363(14): 1341 doi: 10.1056/NEJMra0912063
46
Fatih Demircioğlu, Ali Koçyiğit, Nur Arslan, Handan Çakmakçı, Şamil Hızlı, Alparslan Tuncel Sedat. Intima‐Media Thickness of Carotid Artery and Susceptibility to Atherosclerosis in Obese Children With Nonalcoholic Fatty Liver Disease. Journal of Pediatric Gastroenterology and Nutrition 2008; 47(1): 68 doi: 10.1097/MPG.0b013e31816232c9
47
Clare Nugent, Zobair M Younossi. Evaluation and management of obesity-related nonalcoholic fatty liver disease. Nature Clinical Practice Gastroenterology & Hepatology 2007; 4(8): 432 doi: 10.1038/ncpgasthep0879
48
Hyeon Chang Kim, Dae Jung Kim, Kap Bum Huh. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis 2009; 204(2): 521 doi: 10.1016/j.atherosclerosis.2008.09.012
49
Giovanni Targher, Amedeo Lonardo, Christopher D. Byrne. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nature Reviews Endocrinology 2018; 14(2): 99 doi: 10.1038/nrendo.2017.173
50
Henry Völzke, Dietrich Alte, Till Ittermann, Carsten O. Schmidt, Rainer Rettig, Julia Mayerle, Albert B. Lowenfels, Markus M. Lerch, Matthias Nauck. Subjects with sonographical hepatic steatosis should be excluded from studies to establish upper reference levels of serum transaminases. Liver International 2011; 31(7): 985 doi: 10.1111/j.1478-3231.2010.02371.x
51
Marcello Ricardo Paulista Markus, Peter J. Meffert, Sebastian Edgar Baumeister, Wolfgang Lieb, Ulrike Siewert, Sabine Schipf, Manja Koch, Jan A. Kors, Stephan Burkhard Felix, Marcus Dörr, Giovanni Targher, Henry Völzke. Association between hepatic steatosis and serum liver enzyme levels with atrial fibrillation in the general population. Atherosclerosis 2016; 245: 123 doi: 10.1016/j.atherosclerosis.2015.12.023
52
Amedeo Lonardo, Silvia Lombardini, Federica Scaglioni, Stefano Ballestri, Anna Maria Verrone, Marco Bertolotti, Lucia Carulli, Dorval Ganazzi, Nicola Carulli, Paola Loria. Fatty liver, carotid disease and gallstones: A study of age-related associations. World Journal of Gastroenterology 2006; 12(36): 5826-5833 doi: 10.3748/wjg.v12.i36.5826
53
Henry Völzke, Nicole Aumann, Alexander Krebs, Matthias Nauck, Antje Steveling, Markus M. Lerch, Dieter Rosskopf, Henri Wallaschofski. Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men. International Journal of Andrology 2010; 33(1): 45 doi: 10.1111/j.1365-2605.2009.00953.x
54
Marcello Ricardo Paulista Markus, Sebastian Edgar Baumeister, Jan Stritzke, Marcus Dörr, Henri Wallaschofski, Henry Völzke, Wolfgang Lieb. Hepatic Steatosis Is Associated With Aortic Valve Sclerosis in the General Population. Arteriosclerosis, Thrombosis, and Vascular Biology 2013; 33(7): 1690 doi: 10.1161/ATVBAHA.112.300556
55
Abdurrahman Kadayifci, Vivian Tan, Philip C. Ursell, Raphael B. Merriman, Nathan M. Bass. Clinical and pathologic risk factors for atherosclerosis in cirrhosis: A comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies. Journal of Hepatology 2008; 49(4): 595 doi: 10.1016/j.jhep.2008.05.024
56
Raseen Tariq, Page Axley, Ashwani K. Singal. Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review. Journal of Clinical and Experimental Hepatology 2020; 10(1): 81 doi: 10.1016/j.jceh.2019.07.008
57
K. H. Williams, N. A. Shackel, M. D. Gorrell, S. V. McLennan, S. M. Twigg. Diabetes and Nonalcoholic Fatty Liver Disease: A Pathogenic Duo. Endocrine Reviews 2013; 34(1): 84 doi: 10.1210/er.2012-1009
58
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández Mijares, Teresa Mantilla, Jesús Millán, Juan Pedro-Botet. Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (i). Nonalcoholic fatty liver disease and its association with cardiovascular disease. Clínica e Investigación en Arteriosclerosis (English Edition) 2017; 29(3): 141 doi: 10.1016/j.artere.2016.06.001
59
Sebastian Larion, Caleb A. Padgett, James D. Mintz, Jennifer A. Thompson, Joshua T. Butcher, Eric. J. Belin de Chantemèle, Stephen Haigh, Sandeep Khurana, David J. Fulton, David W. Stepp. NADPH oxidase 1 promotes hepatic steatosis in obese mice and is abrogated by augmented skeletal muscle mass. American Journal of Physiology-Gastrointestinal and Liver Physiology 2024; 326(3): G264 doi: 10.1152/ajpgi.00153.2023
60
Itishree Trivedi, Mary E. Rinella. NAFLD and Cardiovascular Disease: Can the Real Association Be Determined?. Current Hepatology Reports 2014; 13(2): 130 doi: 10.1007/s11901-014-0231-9
61
Samshol Sukahri, Fatimah Zaherah Mohamed Shah, Ahmad Izuanuddin Ismail, Marymol Koshy, Bushra Johari, Mazuin Mohd Razali, Thuhairah Hasrah Abdul Rahman, Mohamad Rodi Isa, Rohana Abdul Ghani, James Andrew Rowley. Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease. PLOS ONE 2021; 16(6): e0253298 doi: 10.1371/journal.pone.0253298
62
Angel Brea, José Puzo. Non-alcoholic fatty liver disease and cardiovascular risk. International Journal of Cardiology 2013; 167(4): 1109 doi: 10.1016/j.ijcard.2012.09.085
63
Claudio Carallo, Gerardo Mancuso, Gaetano Mauro, Ferdinando Laghi, Bruno Madafferi, Concetta Irace, Agostino Gnasso, Faustina Scavelli, Ferruccio Dell’Aquila, Mosè Bartone, Francesco Gullo, Maria Ferraro, Vitaliano Spagnuolo, Maria Belmonte, Antonio Ferrara, Antonio Silvano Rotondaro, Nicola Brandolino, Francesca Parasporo, Francesco Scopelliti. Hepatic steatosis, carotid atherosclerosis and metabolic syndrome: the STEATO Study. Journal of Gastroenterology 2009; 44(11): 1156 doi: 10.1007/s00535-009-0125-8
64
Maria Del Ben, Francesco Baratta, Licia Polimeni, Francesco Angelico. Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences. Internal and Emergency Medicine 2012; 7(S3): 291 doi: 10.1007/s11739-012-0819-4
65
Nicole J Barshop, Cameron S Francis, Jeffrey B Schwimmer, Joel E Lavine. Nonalcoholic Fatty Liver Disease as a Comorbidity of Childhood Obesity. Pediatric Health 2009; 3(3): 271 doi: 10.2217/phe.09.21
66
Henry Völzke, Till Ittermann, Carsten Oliver Schmidt, Sebastian E. Baumeister, Sabine Schipf, Dietrich Alte, Reiner Biffar, Ulrich John, Wolfgang Hoffmann. Prevalence Trends in Lifestyle-Related Risk Factors. Deutsches Ärzteblatt international 2015;  doi: 10.3238/arztebl.2015.0185
67
Leyla Akın, Selim Kurtoglu, Ali Yikilmaz, Mustafa Kendirci, Ferhan Elmalı, Mümtaz Mazicioglu. Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation. Acta Paediatrica 2013; 102(3) doi: 10.1111/apa.12099
68
G. Targher, L. Bertolini, R. Padovani, F. Poli, L. Scala, L. Zenari, G. Zoppini, G. Falezza. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled Type 2 diabetic patients. Journal of Endocrinological Investigation 2006; 29(1): 55 doi: 10.1007/BF03349177
69
Rosemay A. Remigio-Baker, Matthew A. Allison, Nketi I. Forbang, Rohit Loomba, Cheryl A.M. Anderson, Matthew Budoff, Jeffrey B. Schwimmer, Roger S. Blumenthal, Pamela Ouyang, Michael H. Criqui. Race/ethnic and sex disparities in the non-alcoholic fatty liver disease-abdominal aortic calcification association: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2017; 258: 89 doi: 10.1016/j.atherosclerosis.2016.11.021
70
A. Baragetti, G. Pisano, C. Bertelli, K. Garlaschelli, L. Grigore, A.L. Fracanzani, S. Fargion, G.D. Norata, A.L. Catapano. Subclinical atherosclerosis is associated with Epicardial Fat Thickness and hepatic steatosis in the general population. Nutrition, Metabolism and Cardiovascular Diseases 2016; 26(2): 141 doi: 10.1016/j.numecd.2015.10.013
71
Lokpal S. Bhatia, Nicholas P. Curzen, Philip C. Calder, Christopher D. Byrne. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?. European Heart Journal 2012; 33(10): 1190 doi: 10.1093/eurheartj/ehr453
72
Harry P. F. Peters, Patrick Schrauwen, Petra Verhoef, Christopher D. Byrne, David J. Mela, Andreas F. H. Pfeiffer, Ulf Risérus, Frits R. Rosendaal, Vera Schrauwen-Hinderling. Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop. Journal of Nutritional Science 2017; 6 doi: 10.1017/jns.2017.13
73
Fernando Bril, Romina Lomonaco, Kenneth Cusi. The challenge of managing dyslipidemia in patients with nonalcoholic fatty liver disease. Clinical Lipidology 2012; 7(4): 471 doi: 10.2217/clp.12.47
74
A. Gastaldelli, G. Basta. Ectopic fat and cardiovascular disease: What is the link?. Nutrition, Metabolism and Cardiovascular Diseases 2010; 20(7): 481 doi: 10.1016/j.numecd.2010.05.005
75
Kayur D Patel, Kushala WM Abeysekera, Matko Marlais, Mark JW McPhail, Howard C Thomas, Julie A Fitzpatrick, Adrian KP Lim, Simon D Taylor-Robinson, E Louise Thomas. Recent advances in imaging hepatic fibrosis and steatosis. Expert Review of Gastroenterology & Hepatology 2011; 5(1): 91 doi: 10.1586/egh.10.85
76
Mônica Rodrigues de Araújo Souza, Margareth de Fátima Formiga de Melo Diniz, José Eymard Moraes de Medeiros-Filho, Maria Salete Trigueiro de Araújo. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arquivos de Gastroenterologia 2012; 49(1): 89 doi: 10.1590/S0004-28032012000100015
77
Su-bin Lee, Mi Hyeon Jin, Jeong-Hyun Yoon. The contribution of vitamin D insufficiency to the onset of steatotic liver disease among individuals with metabolic dysfunction. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-57380-9
78
Rachel P Wildman, Imke Janssen, Unab I Khan, Rebecca Thurston, Emma Barinas-Mitchell, Samar R El Khoudary, Susan A Everson-Rose, Rasa Kazlauskaite, Karen A Matthews, Kim Sutton-Tyrrell. Subcutaneous adipose tissue in relation to subclinical atherosclerosis and cardiometabolic risk factors in midlife women. The American Journal of Clinical Nutrition 2011; 93(4): 719 doi: 10.3945/ajcn.110.007153
79
Josep Puig, Gerard Blasco, Josep Daunis‐i‐Estadella, Emili Loshuertos, Jaume Codina, Víctor Cuba, Rosa Ortiz, Gemma Xifra, Wifredo Ricart, Salvador Pedraza, Massimo Federici, José Manuel Fernández‐Real. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity. Clinical Endocrinology 2015; 83(2): 180 doi: 10.1111/cen.12698
80
Lisa B. VanWagner, Brittany Lapin, Anton I. Skaro, Donald M. Lloyd‐Jones, Mary E. Rinella. Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis. Liver International 2015; 35(12): 2575 doi: 10.1111/liv.12872
81
Giovanni Targher, Lorenzo Bertolini, Roberto Padovani, Giacomo Zoppini, Luciano Zenari, Giancarlo Falezza. Letter to the Editor. Arteriosclerosis, Thrombosis, and Vascular Biology 2005; 25(12): 2687 doi: 10.1161/01.ATV.0000189299.61568.79
82
Patricia Iozzo, Riikka Lautamaki, Ronald Borra, Hanna-Riikka Lehto, Marco Bucci, Antti Viljanen, Jussi Parkka, Virva Lepomaki, Romina Maggio, Riitta Parkkola, Juhani Knuuti, Pirjo Nuutila. Contribution of Glucose Tolerance and Gender to Cardiac Adiposity. The Journal of Clinical Endocrinology & Metabolism 2009; 94(11): 4472 doi: 10.1210/jc.2009-0436
83
Sebastian E. Baumeister, Henry Völzke, Paul Marschall, Ulrich John, Carsten–Oliver Schmidt, Steffen Flessa, Dietrich Alte. Impact of Fatty Liver Disease on Health Care Utilization and Costs in a General Population: A 5-Year Observation. Gastroenterology 2008; 134(1): 85 doi: 10.1053/j.gastro.2007.10.024
84
Frederik Kostka, Till Ittermann, Stefan Groß, Fabian Christopher Laqua, Robin Bülow, Henry Völzke, Marcus Dörr, Jens Peter Kühn, Marcello Ricardo Paulista Markus, Marie‐Luise Kromrey. Cardiac remodelling in non‐alcoholic fatty liver disease in the general population. Liver International 2024; 44(4): 1032 doi: 10.1111/liv.15844
85
Cem Aygun, Orhan Kocaman, Tayfun Sahin, Suleyman Uraz, Ahmet T. Eminler, Altay Celebi, Omer Senturk, Sadettin Hulagu. Evaluation of Metabolic Syndrome Frequency and Carotid Artery Intima-media Thickness as Risk Factors for Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 2008; 53(5): 1352 doi: 10.1007/s10620-007-9998-7
86
Ana Carolina Cardoso, Claudia Cravo, Fernanda Luiza Calçado, Guilherme Rezende, Carlos Frederico F. Campos, João Marcello A. Neto, Rodrigo P. Luz, Jorge André S. Soares, Henrique Sergio Moraes-Coelho, Nathalie C. Leite, Renata M. Perez, Cristiane A. Villela-Nogueira. The performance of M and XL probes of FibroScan for the diagnosis of steatosis and fibrosis on a Brazilian nonalcoholic fatty liver disease cohort. European Journal of Gastroenterology & Hepatology 2020; 32(2): 231 doi: 10.1097/MEG.0000000000001496
87
Paolo Salvi, Raffaele Ruffini, Davide Agnoletti, Elena Magnani, Gabriele Pagliarani, Giulia Comandini, Antonino Praticò, Claudio Borghi, Athanase Benetos, Paolo Pazzi. Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study. Journal of Hypertension 2010; 28(8): 1699 doi: 10.1097/HJH.0b013e32833a7de6
88
Vassilios A Sevastianos, Stephanos J Hadziyannis. Nonalcoholic fatty liver disease: from clinical recognition to treatment. Expert Review of Gastroenterology & Hepatology 2008; 2(1): 59 doi: 10.1586/17474124.2.1.59
89
Ivana Mikolasevic, Sandra Milic, Tamara Turk Wensveen, Ivana Grgic, Ivan Jakopcic, Davor Stimac, Felix Wensveen, Lidija Orlic. Nonalcoholic fatty liver disease - A multisystem disease?. World Journal of Gastroenterology 2016; 22(43): 9488-9505 doi: 10.3748/wjg.v22.i43.9488
90
Vijay Rampally, SaiRaviKiran Biri, InduK Nair, Arvind Vadlakonda. Determination of association between nonalcoholic fatty liver disease and carotid artery atherosclerosis among nondiabetic individuals. Journal of Family Medicine and Primary Care 2020; 9(2): 1182 doi: 10.4103/jfmpc.jfmpc_957_19
91
Vlad Ratziu, Thierry Poynard. Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious†‡. Hepatology 2006; 44(4): 802 doi: 10.1002/hep.21391
92
Silvia Sookoian, Carlos J. Pirola. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review. Journal of Hepatology 2008; 49(4): 600 doi: 10.1016/j.jhep.2008.06.012
93
Yu-Chen Guo, Yong Zhou, Xing Gao, Yan Yao, Bin Geng, Qing-Hua Cui, Ji-Chun Yang, Hong-Pu Hu. Association between Nonalcoholic Fatty Liver Disease and Carotid Artery Disease in a Community-Based Chinese Population. Chinese Medical Journal 2018; 131(19): 2269 doi: 10.4103/0366-6999.241797
94
Hugo Perazzo, Thierry Poynard, Jean-François Dufour. The Interactions of Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases. Clinics in Liver Disease 2014; 18(1): 233 doi: 10.1016/j.cld.2013.09.014
95
Lei Zhang, Kui Pu, Zhonglin Chai, John B. Dixon. Family history of coronary heart disease is associated with a higher incidence of nonalcoholic fatty liver disease: Central obesity the likely link. Obesity Research & Clinical Practice 2007; 1(2): 125 doi: 10.1016/j.orcp.2007.03.001
96
Haruhisa Nakao, Masashi Yoneda. The intertwisted correlations among non-alcoholic fatty liver disease, atherosclerosis, and metabolic syndrome. Journal of Gastroenterology 2009; 44(11): 1162 doi: 10.1007/s00535-009-0140-9
97
Giulio Marchesini, Rebecca Marzocchi. Metabolic Syndrome and NASH. Clinics in Liver Disease 2007; 11(1): 105 doi: 10.1016/j.cld.2007.02.013
98
Jona T. Stahmeyer, Melissa Hemmerling, Birte Burger, Sveja Eberhard, Christian Krauth, Jan Zeidler, Annika Herr, Henning Weseloh, Siegbert Rossol. Die Häufigkeit von diagnostizierten Fettlebererkrankungen (NAFLD) in der deutschen Bevölkerung – Eine Analyse auf der Basis von GKV-Routinedaten. Zeitschrift für Gastroenterologie 2021; 59(08): 851 doi: 10.1055/a-1402-1263
99
Aikaterini Nikoli, Myrsini Orfanidou, Antonis Goulas, Dimitrios G. Goulis, Stergios A. Polyzos. Circulating lipoprotein(a) in patients with nonalcoholic fatty liver disease: a systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2024; 39(12): 2572 doi: 10.1111/jgh.16768
100
G. Targher. Non‐alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabetic Medicine 2007; 24(1): 1 doi: 10.1111/j.1464-5491.2007.02025.x
101
Francesco Giuseppe Foschi, Giorgio Bedogni, Marco Domenicali, Pierluigi Giacomoni, Anna Chiara Dall’Aglio, Francesca Dazzani, Arianna Lanzi, Fabio Conti, Sara Savini, Gaia Saini, Mauro Bernardi, Pietro Andreone, Amalia Gastaldelli, Andrea Casadei Gardini, Claudio Tiribelli, Stefano Bellentani, Giuseppe Francesco Stefanini. Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0906-8
102
Seung-Hyun Ro, Yura Jang, Jiyoung Bae, Isaac M. Kim, Cameron Schaecher, Zachery D. Shomo. Autophagy in Adipocyte Browning: Emerging Drug Target for Intervention in Obesity. Frontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.00022
103
Roy Irwan, Mireille A. Edens, Paul E. Sijens. Assessment of the variations in fat content in normal liver using a fast MR imaging method in comparison with results obtained by spectroscopic imaging. European Radiology 2008; 18(4): 806 doi: 10.1007/s00330-007-0801-0
104
Ramesh Kumar. Hard clinical outcomes in patients with NAFLD. Hepatology International 2013; 7(S2): 790 doi: 10.1007/s12072-013-9455-y
105
Giovanni Tarantino, Genoveffa Pizza, Annamaria Colao, Fabrizio Pasanisi, Paolo Conca, Patrizia Colicchio, Carmine Finelli, Franco Contaldo, Carolina Di Somma, Silvia Savastano. Hepatic steatosis in overweight/obese females: New screening method for those at risk. World Journal of Gastroenterology 2009; 15(45): 5693-5699 doi: 10.3748/wjg.15.5693
106
Uğur Arslan, Sedat Türkoğlu, Serhat Balcioğlu, Yusuf Tavil, Tarkan Karakan, Atiye Çengel. Association between nonalcoholic fatty liver disease and coronary artery disease. Coronary Artery Disease 2007; 18(6): 433 doi: 10.1097/MCA.0b013e3282583c0d
107
Christopher D. Byrne, Rasaq Olufadi, Kimberley D. Bruce, Felino R. Cagampang, Mohamed H. Ahmed. Metabolic disturbances in non-alcoholic fatty liver disease. Clinical Science 2009; 116(7): 539 doi: 10.1042/CS20080253
108
Mauro Maurantonio, Stefano Ballestri, Maria Rosaria Odoardi, Amedeo Lonardo, Paola Loria. Treatment of Atherogenic Liver Based on the Pathogenesis of Nonalcoholic Fatty Liver Disease: A Novel Approach to Reduce Cardiovascular Risk?. Archives of Medical Research 2011; 42(5): 337 doi: 10.1016/j.arcmed.2011.08.004
109
E Rosenthal, P Cacoub. Extrahepatic manifestations in chronic hepatitis C virus carriers. Lupus 2015; 24(4-5): 469 doi: 10.1177/0961203314556140
110
Ingrid J. Hickman, Clair M. Sullivan, Simone Flight, Catherine Campbell, Darrell H. Crawford, Paul P. Masci, Trisha M. O’Moore-Sullivan, Johannes B. Prins, Graeme A. Macdonald. Altered clot kinetics in patients with non-alcoholic fatty liver disease. Annals of Hepatology 2009; 8(4): 331 doi: 10.1016/S1665-2681(19)31746-6
111
Ibrahim Cetindağlı, Muammer Kara, Alpaslan Tanoglu, Veysel Ozalper, Serkan Aribal, Yusuf Hancerli, Mehmet Unal, Onur Ozarı, Serdar Hira, Mustafa Kaplan, Yusuf Yazgan. Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: Association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation. Clinics and Research in Hepatology and Gastroenterology 2017; 41(5): 516 doi: 10.1016/j.clinre.2017.01.005
112
Diego Hernando, Jens‐Peter Kühn, Birger Mensel, Henry Völzke, Ralf Puls, Norbert Hosten, Scott B. Reeder. R2* estimation using “in‐phase” echoes in the presence of fat: The effects of complex spectrum of fat. Journal of Magnetic Resonance Imaging 2013; 37(3): 717 doi: 10.1002/jmri.23851
113
Derek Ugwendum, Mouhanad Mohamed, Yazan A Al-Ajlouni, Nso Nso, Basile Njei. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) With an Increased Risk of Congestive Heart Failure in Hospitalized Patients With Cirrhosis: A Propensity Score-Matched Analysis. Cureus 2024;  doi: 10.7759/cureus.62441
114
Ji Hoon Kang, Kyoung Im Cho, Seong Man Kim, Ja Young Lee, Jae Joon Kim, Ja Jun Goo, Kyoung Nyoun Kim, Joon Hyung Jhi, Dong Jun Kim, Hyeon Gook Lee, Tae Ik Kim. Relationship between Nonalcoholic Fatty Liver Disease and Carotid Artery Atherosclerosis Beyond Metabolic Disorders in Non-Diabetic Patients. Journal of Cardiovascular Ultrasound 2012; 20(3): 126 doi: 10.4250/jcu.2012.20.3.126
115
Shunquan Wu, Fuquan Wu, Yingying Ding, Jun Hou, Jingfeng Bi, Zheng Zhang. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis. Scientific Reports 2016; 6(1) doi: 10.1038/srep33386
116
Laura S. Chiu, Alison Pedley, Joseph M. Massaro, Emelia J. Benjamin, Gary F. Mitchell, David D. McManus, Jayashri Aragam, Ramachandran S. Vasan, Susan Cheng, Michelle T. Long. The association of non‐alcoholic fatty liver disease and cardiac structure and function—Framingham Heart Study. Liver International 2020; 40(10): 2445 doi: 10.1111/liv.14600
117
Ruirui Ren, Yang Zheng. Sex differences in cardiovascular and all-cause mortality in nonalcoholic fatty liver disease in the US population. Nutrition, Metabolism and Cardiovascular Diseases 2023; 33(7): 1349 doi: 10.1016/j.numecd.2023.03.003
118
Mohamed H. Ahmed, Emmanuel O. Abu, Christopher D. Byrne. Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?. Primary Care Diabetes 2010; 4(3): 129 doi: 10.1016/j.pcd.2010.02.004
119
Jun Luo, Li Xu, Jiang Li, Shuiping Zhao. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease. European Journal of Gastroenterology & Hepatology 2015; 27(3): 193 doi: 10.1097/MEG.0000000000000254
120
Vlad Ratziu, Stefano Bellentani, Helena Cortez-Pinto, Chris Day, Giulio Marchesini. A position statement on NAFLD/NASH based on the EASL 2009 special conference. Journal of Hepatology 2010; 53(2): 372 doi: 10.1016/j.jhep.2010.04.008
121
C. A. Caserta, G. M. Pendino, A. Amante, C. Vacalebre, M. T. Fiorillo, P. Surace, A. Messineo, M. Surace, S. Alicante, R. Cotichini, M. Zuin, F. Rosmini, A. Mele, F. Marcucci. Cardiovascular Risk Factors, Nonalcoholic Fatty Liver Disease, and Carotid Artery Intima-Media Thickness in an Adolescent Population in Southern Italy. American Journal of Epidemiology 2010; 171(11): 1195 doi: 10.1093/aje/kwq073
122
Mehmet Sayiner, Aaron Koenig, Linda Henry, Zobair M. Younossi. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. Clinics in Liver Disease 2016; 20(2): 205 doi: 10.1016/j.cld.2015.10.001
123
Antonio Picardi, Umberto Vespasiani-Gentilucci. Association Between Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease: A First Message Should Pass. The American Journal of Gastroenterology 2008; 103(12): 3036 doi: 10.1111/j.1572-0241.2008.02196.x
124
G. Targher, F. Marra, G. Marchesini. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?. Diabetologia 2008; 51(11): 1947 doi: 10.1007/s00125-008-1135-4
125
Yuelin Kong, Yue Tong, Chen Chen, Mingming Gao, Xiangdong Gao, Wenbing Yao. Alleviation of high-fat diet-induced atherosclerosis and glucose intolerance by a novel GLP-1 fusion protein in ApoE−/− mice. Endocrine 2016; 53(1): 71 doi: 10.1007/s12020-015-0831-3
126
Ali Mohammadzadeh, Vahid Shahkarami, Madjid Shakiba, Parto Sabetrasekh, Maryam Mohammadzadeh. Association of Non-Alcoholic Fatty Liver Disease with Increased Carotid Intima-Media Thickness Considering Other Cardiovascular Risk Factors. Iranian Journal of Radiology 2019; 16(3) doi: 10.5812/iranjradiol.14260
127
Giovanni Targher, Lorenzo Bertolini, Roberto Padovani, Stefano Rodella, Guido Arcaro, Christopher Day. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. Journal of Hepatology 2007; 46(6): 1126 doi: 10.1016/j.jhep.2007.01.021
128
Robin Haring, Henri Wallaschofski, Matthias Nauck, Marcus Dörr, Sebastian E. Baumeister, Henry Völzke. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels # †. Hepatology 2009; 50(5): 1403 doi: 10.1002/hep.23135
129
Sunmi Kim, Hyuktae Kwon, Jin-Ho Park, Belong Cho, Donghee Kim, Seung-Won Oh, Cheol Min Lee, Ho-Chun Choi. A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-69
130
Radojica V. Stolic, Goran Z. Trajkovic, Mirjana M. Kostic, Sasa R. Sovtic, Andrijana M. Odalovic, Biljana D. Krdzic, Maja V. Sipic, Snezana Lazic, Zorica N. Sojevic-Timotijevic. Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients. International Urology and Nephrology 2016; 48(6): 883 doi: 10.1007/s11255-016-1237-8
131
Leon A Adams, Quentin M Anstee, Herbert Tilg, Giovanni Targher. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 2017; 66(6): 1138 doi: 10.1136/gutjnl-2017-313884
132
Adam J. Buckley, E. Louise Thomas, Nader Lessan, Francesca M. Trovato, Guglielmo M. Trovato, Simon D. Taylor-Robinson. Non-alcoholic fatty liver disease: Relationship with cardiovascular risk markers and clinical endpoints. Diabetes Research and Clinical Practice 2018; 144: 144 doi: 10.1016/j.diabres.2018.08.011
133
G. Targher, L. Bertolini, R. Padovani, F. Poli, L. Scala, R. Tessari, L. Zenari, G. Falezza. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non‐alcoholic fatty liver disease. Diabetic Medicine 2006; 23(4): 403 doi: 10.1111/j.1464-5491.2006.01817.x
134
Katharina Piontek, Carsten O Schmidt, Sebastian E Baumeister, Markus M Lerch, Julia Mayerle, Marcus Dörr, Stephan B Felix, Henry Völzke. Is hepatic steatosis associated with left ventricular mass index increase in the general population?. World Journal of Hepatology 2017; 9(19): 857-866 doi: 10.4254/wjh.v9.i19.857
135
Lisa B. VanWagner, James G. Terry, Lisa S. Chow, Amy C. Alman, Hakmook Kang, Katherine H. Ingram, Christina Shay, Cora E. Lewis, R. Nick Bryan, Lenore J. Launer, J. Jeffrey Carr. Nonalcoholic fatty liver disease and measures of early brain health in middle‐aged adults: The CARDIA study. Obesity 2017; 25(3): 642 doi: 10.1002/oby.21767
136
Banu D. Ozel Coskun, Mehmet Yucesoy, Sebnem Gursoy, Mevlut Baskol, Alper Yurci, Ahmet Yagbasan, Serap Doğan, Gulden Baskol. Effects of ursodeoxycholic acid therapy on carotid intima media thickness, apolipoprotein A1, apolipoprotein B, and apolipoprotein B/A1 ratio in nonalcoholic steatohepatitis. European Journal of Gastroenterology & Hepatology 2015; 27(2): 142 doi: 10.1097/MEG.0000000000000264
137
Ho Cheol Hong, Soon Young Hwang, Ja Young Ryu, Hye Jin Yoo, Ji‐A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Dong Seop Choi, Kyung Mook Choi. The synergistic impact of nonalcoholic fatty liver disease and metabolic syndrome on subclinical atherosclerosis. Clinical Endocrinology 2016; 84(2): 203 doi: 10.1111/cen.12940
138
Mohamed H. Ahmed, Salma Barakat, Ahmed O. Almobarak. Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Has the Time Come for Cardiologists to Be Hepatologists?. Journal of Obesity 2012; 2012: 1 doi: 10.1155/2012/483135
139
Michaela Kozakova, Carlo Palombo, Marco Paterni Eng, Jacqueline Dekker, Allan Flyvbjerg, Asimina Mitrakou, Amalia Gastaldelli, Ele Ferrannini. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Hepatology 2012; 55(5): 1406 doi: 10.1002/hep.25555
140
Lisa B. VanWagner, Hongyan Ning, Cora E. Lewis, Christina M. Shay, John Wilkins, J. Jeffrey Carr, James G. Terry, Donald M. Lloyd-Jones, David R. Jacobs, Mercedes R. Carnethon. Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The Coronary Artery Risk Development in Young Adults Study. Atherosclerosis 2014; 235(2): 599 doi: 10.1016/j.atherosclerosis.2014.05.962
141
Ying-Hsiang Lee, Yih-Jer Wu, Chuan-Chuan Liu, Charles Jia-Yin Hou, Hung-I. Yeh, Cheng-Ho Tsai, Shou-Chuan Shih, Chung-Lieh Hung. The Severity of Fatty Liver Disease Relating to Metabolic Abnormalities Independently Predicts Coronary Calcification. Radiology Research and Practice 2011; 2011: 1 doi: 10.1155/2011/586785
142
Eline H. van den Berg, Marzyeh Amini, Tim C. M. A. Schreuder, Robin P. F. Dullaart, Klaas Nico Faber, Behrooz Z. Alizadeh, Hans Blokzijl, Salvatore Petta. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort. PLOS ONE 2017; 12(2): e0171502 doi: 10.1371/journal.pone.0171502
143
Amedeo Lonardo, Fabio Nascimbeni, Alessandro Mantovani, Giovanni Targher. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?. Journal of Hepatology 2018; 68(2): 335 doi: 10.1016/j.jhep.2017.09.021
144
Lisa B. VanWagner, Jane E. Wilcox, Hongyan Ning, Cora E. Lewis, John Jeffrey Carr, Mary E. Rinella, Sanjiv J. Shah, Joao A. C. Lima, Donald M. Lloyd‐Jones. Longitudinal Association of Non‐Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study. Journal of the American Heart Association 2020; 9(4) doi: 10.1161/JAHA.119.014279
145
Jan Zeidler, Ansgar Lange, Johann-Matthias von der Schulenburg. Nicht-alkoholische Fettlebererkrankung. 2022; : 385 doi: 10.1007/978-3-662-62484-5_34
146
Jian‐Gao Fan, Toshiji Saibara, Shivakumar Chitturi, Byong Ik Kim, Joseph J Y Sung, A Chutaputti. What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific?. Journal of Gastroenterology and Hepatology 2007; 22(6): 794 doi: 10.1111/j.1440-1746.2007.04952.x
147
Winston Dunn, Ronghui Xu, Deborah L. Wingard, Christopher Rogers, Paul Angulo, Zobair M. Younossi, Jeffrey B. Schwimmer. Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study. The American Journal of Gastroenterology 2008; 103(9): 2263 doi: 10.1111/j.1572-0241.2008.02034.x
148
Lisa B. VanWagner, Jane E. Wilcox, Laura A. Colangelo, Donald M. Lloyd‐Jones, J. Jeffrey Carr, Joao A. Lima, Cora E. Lewis, Mary E. Rinella, Sanjiv J. Shah. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population‐based study. Hepatology 2015; 62(3): 773 doi: 10.1002/hep.27869
149
Ralph L. Widya, Renée de Mutsert, Jos J. M. Westenberg, Karin B. Gast, Martin den Heijer, Saskia le Cessie, Johannes W. A. Smit, J. Wouter Jukema, Frits R. Rosendaal, Albert de Roos, Hildo J. Lamb. Is Hepatic Triglyceride Content Associated with Aortic Pulse Wave Velocity and Carotid Intima-Media Thickness? The Netherlands Epidemiology of Obesity Study. Radiology 2017; 285(1): 73 doi: 10.1148/radiol.2017160916
150
Cinthia Choque Vargas, Francisco Cáceres, Graciela Landeira, Soledad Perez, Laura Marchi, Gabriela Ruffillo, Silvina Tevez, Miguel Puga-Tejada, Eduardo Fassio. Cardiovascular events and incident diabetes in 220 patients with MASLD according to basal liver fibrosis: a 10-year follow-up historic cohort. European Journal of Gastroenterology & Hepatology 2025;  doi: 10.1097/MEG.0000000000002943
151
Michael H. Le, Yee Hui Yeo, Xiaohe Li, Jie Li, Biyao Zou, Yuankai Wu, Qing Ye, Daniel Q. Huang, Changqing Zhao, Jie Zhang, Chenxi Liu, Na Chang, Feng Xing, Shiping Yan, Zi Hui Wan, Natasha Sook Yee Tang, Maeda Mayumi, Xinting Liu, Chuanli Liu, Fajuan Rui, Hongli Yang, Yao Yang, Ruichun Jin, Richard H.X. Le, Yayun Xu, David M. Le, Scott Barnett, Christopher Donald Stave, Ramsey Cheung, Qiang Zhu, Mindie H. Nguyen. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2022; 20(12): 2809 doi: 10.1016/j.cgh.2021.12.002
152
Anna Ludovica Fracanzani, Larry Burdick, Sara Raselli, Paola Pedotti, Liliana Grigore, Gennaro Santorelli, Luca Valenti, Alessandra Maraschi, Alberico Catapano, Silvia Fargion. Carotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease. The American Journal of Medicine 2008; 121(1): 72 doi: 10.1016/j.amjmed.2007.08.041
153
M. A. Edens, F. Kuipers, R. P. Stolk. Non‐alcoholic fatty liver disease is associated with cardiovascular disease risk markers. Obesity Reviews 2009; 10(4): 412 doi: 10.1111/j.1467-789X.2009.00594.x
154
Leticia Elizondo-Montemayor, Patricia A. Ugalde-Casas, Lorena Lam-Franco, Humberto Bustamante-Careaga, Mónica Serrano-González, Norma G. Gutiérrez, Ubaldo Martínez. Association of ALT and the metabolic syndrome among Mexican children. Obesity Research & Clinical Practice 2014; 8(1): e79 doi: 10.1016/j.orcp.2012.08.191
155
Till Ittermann, Robin Haring, Henri Wallaschofski, Sebastian E. Baumeister, Matthias Nauck, Marcus Dörr, Markus M Lerch, Henriette Meyer zu Schwabedissen, Dieter Rosskopf, Henry Völzke. Inverse Association Between Serum Free Thyroxine Levels and Hepatic Steatosis: Results From the Study of Health in Pomerania. Thyroid 2012; : 120308105738004 doi: 10.1089/thy.2011-0279
156
Kenneth Cusi. Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications. Gastroenterology 2012; 142(4): 711 doi: 10.1053/j.gastro.2012.02.003
157
Shivank A. Madan, Febin John, Nikolaos Pyrsopoulos, Capecomorin S. Pitchumoni. Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults. European Journal of Gastroenterology & Hepatology 2015; 27(11): 1237 doi: 10.1097/MEG.0000000000000429
158
Ashraf Abd El-Khalik Barakat, Fatma Mohammad Nasr, Amna Ahmed Metwaly, Sherif Morsy, Mervat Eldamarawy. Atherosclerosis in chronic hepatitis C virus patients with and without liver cirrhosis. The Egyptian Heart Journal 2017; 69(2): 139 doi: 10.1016/j.ehj.2016.10.004
159
Guldem Kilciler, Halil Genc, Serkan Tapan, Fatih Ors, Muammer Kara, Nuri Karadurmus, C. Nuri Ercin, Yildirim Karslioglu, Selim Kilic, Sait Bagci, M. Kemal Erbil, Teoman Dogru. Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease. Upsala Journal of Medical Sciences 2010; 115(4): 253 doi: 10.3109/03009734.2010.500062
160
Natalia Guillén, Sergio Acín, María A. Navarro, Javier S. Perona, José M. Arbonés-Mainar, Carmen Arnal, Alfonso J. Sarría, Joaquín C. Surra, Ricardo Carnicer, Israel Orman, Jose C. Segovia, Valentina Ruiz-Gutiérrez, Jesús Osada. Squalene in a sex-dependent manner modulates atherosclerotic lesion which correlates with hepatic fat content in apoE-knockout male mice. Atherosclerosis 2008; 197(1): 72 doi: 10.1016/j.atherosclerosis.2007.08.008
161
Stefano Ramilli, Stefano Pretolani, Antonio Muscari, Barbara Pacelli, Vincenzo Arienti. Carotid lesions in outpatients with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2009; 15(38): 4770-4774 doi: 10.3748/wjg.15.4770
162
Rosa Zampino, Aldo Marrone, Luciano Restivo, Barbara Guerrera, Ausilia Sellitto, Luca Rinaldi, Ciro Romano, Luigi E Adinolfi. Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World Journal of Hepatology 2013; 5(10): 528-540 doi: 10.4254/wjh.v5.i10.528
163
Antonio Barbato, Roberto Iacone, Giovanni Tarantino, Ornella Russo, Paolo Sorrentino, Sonia Avallone, Ferruccio Galletti, Eduardo Farinaro, Elisabetta Della Valle, Pasquale Strazzullo. Relationships of PAI-1 levels to central obesity and liver steatosis in a sample of adult male population in southern Italy. Internal and Emergency Medicine 2009; 4(4): 315 doi: 10.1007/s11739-009-0240-9
164
Colleen N. Feriod, Andre Gustavo Oliveira, Mateus T. Guerra, Lily Nguyen, Kisha Mitchell Richards, Michael J. Jurczak, Hai‐Bin Ruan, Joao Paulo Camporez, Xiaoyong Yang, Gerald I. Shulman, Anton M. Bennett, Michael H. Nathanson, Barbara E. Ehrlich. Hepatic inositol 1,4,5 trisphosphate receptor type 1 mediates fatty liver. Hepatology Communications 2017; 1(1): 23 doi: 10.1002/hep4.1012
165
Kun Huang, Hanjoong Jo, Jing Echesabal-Chen, Alexis Stamatikos. Combined LXR and RXR Agonist Therapy Increases ABCA1 Protein Expression and Enhances ApoAI-Mediated Cholesterol Efflux in Cultured Endothelial Cells. Metabolites 2021; 11(9): 640 doi: 10.3390/metabo11090640
166
Victoria Greenfield, Onpan Cheung, Arun J Sanyal. Recent advances in nonalcholic fatty liver disease. Current Opinion in Gastroenterology 2008; 24(3): 320 doi: 10.1097/MOG.0b013e3282fbccf2
167
Yu-Cheng Lin, Jong-Dar Chen. Association Between Sonographic Fatty Liver and Ischemic Electrocardiogram Among Non-obese Taiwanese Male Adults. Journal of Medical Ultrasound 2006; 14(3): 58 doi: 10.1016/S0929-6441(09)60092-8
168
Mohamed H. Ahmed, Christopher D. Byrne. The Metabolic Syndrome. 2011; : 245 doi: 10.1002/9781444347319.ch15
169
Marco Matteo Ciccone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo, Gabriella Ricci, Santa Carbonara, Michele Gesualdo, Fiorella Devito, Annapaola Zito, Francesca Cortese, Pietro Scicchitano. Inflammatory bowel disease, liver diseases and endothelial function. Journal of Cardiovascular Medicine 2015; 16(1): 11 doi: 10.2459/JCM.0000000000000149
170
Licia Polimeni, Maria Del Ben, Francesco Baratta, Ludovica Perri, Fabiana Albanese, Daniele Pastori, Francesco Violi, Francesco Angelico. Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis. World Journal of Hepatology 2015; 7(10): 1325-1336 doi: 10.4254/wjh.v7.i10.1325
171
Ebenezer T. Oni, Arthur S. Agatston, Michael J. Blaha, Jonathan Fialkow, Ricardo Cury, Andrei Sposito, Raimund Erbel, Ron Blankstein, Ted Feldman, Mouaz H. Al-Mallah, Raul D. Santos, Matthew J. Budoff, Khurram Nasir. A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?. Atherosclerosis 2013; 230(2): 258 doi: 10.1016/j.atherosclerosis.2013.07.052
172
Sandhya Mishra, Dharamveer Yadav, Monika Gupta, Hemant Mishra, Praveen Sharma. A Study of Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease. Indian Journal of Clinical Biochemistry 2013; 28(1): 79 doi: 10.1007/s12291-012-0286-8
173
Matthias Claus, Christoph Antoni, Bernd Hofmann. Factors associated with elevated alanine aminotransferase in employees of a German chemical company: results of a large cross-sectional study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01601-2
174
H. Volzke, D. Alte, C. O. Schmidt, D. Radke, R. Lorbeer, N. Friedrich, N. Aumann, K. Lau, M. Piontek, G. Born, C. Havemann, T. Ittermann, S. Schipf, R. Haring, S. E. Baumeister, H. Wallaschofski, M. Nauck, S. Frick, A. Arnold, M. Junger, J. Mayerle, M. Kraft, M. M. Lerch, M. Dorr, T. Reffelmann, K. Empen, S. B. Felix, A. Obst, B. Koch, S. Glaser, R. Ewert, I. Fietze, T. Penzel, M. Doren, W. Rathmann, J. Haerting, M. Hannemann, J. Ropcke, U. Schminke, C. Jurgens, F. Tost, R. Rettig, J. A. Kors, S. Ungerer, K. Hegenscheid, J.-P. Kuhn, J. Kuhn, N. Hosten, R. Puls, J. Henke, O. Gloger, A. Teumer, G. Homuth, U. Volker, C. Schwahn, B. Holtfreter, I. Polzer, T. Kohlmann, H. J. Grabe, D. Rosskopf, H. K. Kroemer, T. Kocher, R. Biffar, U. John, W. Hoffmann. Cohort Profile: The Study of Health in Pomerania. International Journal of Epidemiology 2011; 40(2): 294 doi: 10.1093/ije/dyp394
175
Chia-Hung Chiang, Chin-Chou Huang, Wan-Leong Chan, Jaw-Wen Chen, Hsin-Bang Leu. The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population. Clinical Biochemistry 2010; 43(18): 1399 doi: 10.1016/j.clinbiochem.2010.09.003
176
Enzo Bonora, Giovanni Targher. Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nature Reviews Gastroenterology & Hepatology 2012; 9(7): 372 doi: 10.1038/nrgastro.2012.79
177
J.-P. Kühn, M.C. Spoerl, C. Mahlke, K. Hegenscheid. Techniken zur Leberfettquantifizierung bei der Risikostratifikation von Diabetikern. Der Radiologe 2015; 55(4): 308 doi: 10.1007/s00117-014-2720-9
178
Jimmy Narayan, Haribhakti Seba Das, Preetam Nath, Ayaskanta Singh, Debakanta Mishra, Pradeep Kumar Padhi, Shivaram Prasad Singh. Endothelial Dysfunction, a Marker of Atherosclerosis, Is Independent of Metabolic Syndrome in NAFLD Patients. International Journal of Hepatology 2020; 2020: 1 doi: 10.1155/2020/1825142
179
Josep León-Mengíbar, Enric Sánchez, Ferrán Herrerías, Mari Cruz De La Fuente, Maite Santamaría, José Manuel Valdivielso, Marcelino Bermúdez-López, Eva Castro, Judit Pallarés, Xavier Matias-Guiu, Felip Vilardell, Assumpta Caixàs, Marta Bueno, Raquel Martí, Albert Lecube. Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1366015
180
Cornelia Weikert, Norbert Stefan, Matthias B. Schulze, Tobias Pischon, Klaus Berger, Hans-Georg Joost, Hans-Ulrich Häring, Heiner Boeing, Andreas Fritsche. Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke. Circulation 2008; 118(24): 2555 doi: 10.1161/CIRCULATIONAHA.108.814418
181
Hak Soo Kim, Yong Kyun Cho. Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease. The Korean Journal of Gastroenterology 2017; 69(6): 333 doi: 10.4166/kjg.2017.69.6.333
182
Varanasi Yugandar Bhargav, Mayank Jain, Tom Alen, Chandan Kumar Kedarisetty, Preetam Arthur, Mu Karthikeyan, Thamarai S. Selvan, Jayanthi Venkataraman. Clusters and Components of Metabolic Syndrome (MeS) as a Predictor for Fatty Liver. Journal of Diabetology 2021; 12(4): 434 doi: 10.4103/jod.jod_17_21
183
Daniel Weghuber, Michael Roden, Carlo Franz, Marek Chmelik, Sherin Torabia, Peter Nowotny, Stephan Gruber, Werner Waldhäusl, Anton Klingler, Christian Bieglmayer, Martin Bischof, Michael Wolzt, Georg Schaller, Kurt Widhalm. Vascular function in obese children with non-alcoholic fatty liver disease. International Journal of Pediatric Obesity 2011; 6(2): 120 doi: 10.3109/17477161003792580
184
Luigi E. Adinolfi, Luciano Restivo, Rosa Zampino, Barbara Guerrera, Amedeo Lonardo, Laura Ruggiero, Francesco Riello, Paola Loria, Anna Florio. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis. Atherosclerosis 2012; 221(2): 496 doi: 10.1016/j.atherosclerosis.2012.01.051
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345